AbCellera Biologics Inc. Stock Price, News, Quote & History

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

AbCellera Biologics Inc.

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

AbCellera Reports Q3 2025 Business Results

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

5 US Longevity and Anti-aging Stocks to Watch in 2025

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Latest News

Rockwell Automation Introduces SecureOT Solution Suite to Strengthen Industrial Cybersecurity Resilience

SurgePays Revenue for the Third Quarter 2025 Increases 292% Year-Over-Year and 62% Sequentially

Avalon Announces Conclusion of Funding Agreement

ProStar Announces The Addition Of GroundBreakers Utility Management Company To Its Growing List Of Enterprise Clients

Patrick Ryan's Buckeye Tops Amazon's Best Books of 2025 List

Latest News

Outlook Reports world

Featured Biotech Investing Stocks

Browse Companies